Zepbound may not be as widely known as its competitors, but the weight-loss drug may soon be more accessible than the rest. Eli Lilly, the manufacturer of Zepbound, which is FDA-approved to help treat obesity and obesity with obstructive sleep apnea,

U.S. pharmaceutical giant Eli Lilly (LLY) is lowering the cost of its weight loss drug Zepbound as it seeks to expand consumer access to the medication. The company has announced that it is selling higher doses of Zepbound in single-dose vials